78
Views
12
CrossRef citations to date
0
Altmetric
Clinical Focus: Pain Management

Indomethacin Submicron Particle Capsules Provide Effective Pain Relief in Patients with Acute Pain: A Phase 3 Study

, MD, , DO & , MD
Pages 7-15 | Published online: 13 Mar 2015

References

  • . Indomethacin [package insert]. Prescribing Information. Edison, NJ: Heritage Pharmaceuticals, Inc; 2010
  • . , Coxib and Traditional NSAID Trialists' (CNT) CollaborationBhala N, Emberson J, Merhi A, . Vascular and upper gastrointestinal effects of Nonsteroidal antiinflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769–779
  • . Rostom A, Goldkind L, Laine L. Nonsteroidal anti-inflammatory drugs and hepatic toxicity: a systematic review of randomized controlled trials in arthritis patients. Clin Gastroenterol Hepatol. 2005;3(5):489–498
  • . Schneider V, Levesque LE, Zhang B, Hutchinson T, Brophy JM. Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis. Am J Epidemiol. 2006;164(9):881–889
  • . Lewis SC, Langman MJ, Laporte JR, Matthews JN, Rawlins MD, Wiholm BE. Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. Br J Clin Pharmacol. 2002;54(3):320–326
  • . Riera-Guardia N, Castellsague J, Calingaert B, . The SOS Project: nonsteroidal anti-inflammatory drugs and upper gastrointenstinal complications. Meta-analysis of epidemiological studies. Presented at: International Conference on Pharmacoepidemiology; 2010; Brighton, United Kingdom. http://www.sos-nsaids-project.org/public-dissemination-activities/N.Riera_ISPE%20Poster%20%28GI%29_8–2.pdf
  • . Graham DJ, Campen D, Hui R, . Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet. 2005;365(9458):475–481
  • . McGettigan P, Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med. 2011;8(9):e1001098
  • . Brater DC. Anti-inflammatory agents and renal function. Semin Arthritis Rheum. 2002;32(3 Suppl 1):33–42
  • . Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med. 1999;106(5B):13S–24S
  • . Health Canada. Basic product monograph information for nonsteroidal anti-inflammatory drugs (NSAIDS). http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/nsaid-ains/nsaids_ains-eng.php. Accessed October 4, 2012
  • . Watson R. European Medicines Agency gives favourable ruling on NSAIDs. BMJ. 2006;333(7574):873
  • . European Medicines Agency finalises review of recent published data on cardiovascular safety of NSAIDs [press release]. London: European Medicines Agency; October 19, 2012
  • . Public Health Advisory: FDA Announces Important Changes and Additional Warnings for COX-2 Selective and Non-Selective Non-Steroidal Anti-inflammatory Drugs (NSAIDs) [press release]. Silver Spring, MD: US Food and Drug Administration; April 7, 2005
  • . No authors listed World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2000;284(23):3043–3045
  • . Daniels SE, Baum DR, Clark F, Golf MH, McDonnell ME, Boesing SE. Diclofenac potassium liquid-filled soft gelatin capsules for the treatment of postbunionectomy pain. Curr Med Res Opin. 2010;26(10):2375–2384
  • . Manvelian G, Daniels S, Altman R. A phase I study evaluating the pharmacokinetic profile of a novel, proprietary, nano-formulated, lower-dose oral indomethacin. Postgrad Med. 2012;124(4):197–205
  • . Manvelian G, Hochberg M, Daniels S, Altman R, Young C. A phase 2 study of lower-dose indomethacin submicron particle capsules demonstrates early onset of acute pain relief. Clin J Pain. In press
  • . Daniels S, Casson E, Stegmann JU, . A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain. Curr Med Res Opin. 2009;25(6):1551–1561
  • . Riff DS, Duckor S, Gottlieb I, . Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: A Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days. Clin Ther. 2009;31(10):2072–2085
  • . Johnsen SP, Larsson H, Tarone RE, . Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: A population-based case-control study. Arch Intern Med. 2005;165(9):978–984
  • . Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006;332(7553):1302–1308
  • . Helin-Salmivaara A, Virtanen A, Vesalainen R, . NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland. Eur Heart J. 2006;27(14):1657–1663
  • . Huerta C, Castellsague J, Varas-Lorenzo C, Garcia Rodriguez LA. Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis. 2005;45(3):531–539
  • . Hochberg MC, Fort JG, Svensson O, Hwang C, Sostek M. Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: Two randomized trials. Curr Med Res Opin. 2011;27(6):1243–1253
  • . Gigante A, Tagarro I. Non-steroidal anti-inflammatory drugs and gastroprotection with proton pump inhibitors: A focus on ketoprofen/omeprazole. Clin Drug Investig. 2012;32(4):221–233
  • . Laine L, Kivitz AJ, Bello AE, Grahn AY, Schiff MH, Taha AS. Double-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers. Am J Gastroenterol. 2012;107(3):379–386
  • . Bensen W, Weaver A, Espinoza L, . Efficacy and safety of valdecoxib in treating the signs and symptoms of rheumatoid arthritis: A randomized, controlled comparison with placebo and naproxen. Rheumatology (Oxford). 2002;41(9):1008–1016
  • . Christensen KS, Cawkwell GD. Valdecoxib versus rofecoxib in acute postsurgical pain: Results of a randomized controlled trial. J Pain Symptom Manage. 2004;27(5):460–470
  • . Derry S, Moore RA. Single dose oral celecoxib for acute postoperative pain in adults. Cochrane Database Syst Rev. 2012;3:CD004233
  • . Derry S, Moore RA, Rabbie R. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2012;9:CD007400
  • . Walker AM, Chan KW, Yood RA. Patterns of interchange in the dispensing of non-steroidal anti-inflammatory drugs. J Clin Epidemiol 1992;45(2):187–195
  • . Gore M, Sadosky AB, Leslie DL, Tai KS, Emery P. Therapy switching, augmentation, and discontinuation in patients with osteoarthritis and chronic low back pain. Pain Pract. 2012;12(6):457–468
  • . Rosemann T, Wensing M, Joest K, Backenstrass M, Mahler C, Szecsenyi J. Problems and needs for improving primary care of osteoarthritis patients: the views of patients, general practitioners and practice nurses. BMC Musculoskelet Disord. 2006;7:48

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.